Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively ...

Background Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic arthritis (PsA ... Stable background treatment of non-steroidal anti-inflammatory drugs, ...

regionh.dk Objective To evaluate risankizumab, a biological therapy that inhibits interleukin 23, in patients with active psoriatic arthritis (PsA ... First-line PsA treatment includes non-steroidal ...

Bristol Myers Squibb today announced new five-year results from the POETYK PSO long-term extension (LTE) trial of Sotyktu (deucravacitinib) treatment in adult patients with moderate-to-severe plaque ...

Although psoriatic arthritis may be more prevalent in White patients, Rebecca Haberman, MD, of NYU Langone Health, emphasizes that the disease affects those across diverse racial and ethnic ...

Do newer types of biologics increase the risk of MACE and VTE more than older TNFs in patients with psoriasis or psoriatic arthritis? Share on Facebook. Opens in a new tab or window Share on Bluesky.

Holum, Inc. team lead with psoriatic arthritis can’t proceed, an Indiana federal district court ruled, because the decision to fire her occurred two days before she informed a manager she was filing ...

Patients receiving an immune checkpoint inhibitor for a neoplasm face an increased risk for rheumatoid arthritis, an ...

For investors eyeing Biocon’s stock, this approval could be a significant catalyst. According to InvestingPro’s fair value ...

UCB SA (OTCMKTS:UCBJF – Get Free Report) saw a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 396,800 shares, a growth of 25.7% from the ...

Exfoliating your scalp removes built-up oil, dead skin cells, and debris. Learn how to do it safely with different techniques ...

An observational cohort study of U.S. military veterans with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis examined missed opportunities for treatment of inflammatory ...